Robert Gemmill to Pancreatic Neoplasms
This is a "connection" page, showing publications Robert Gemmill has written about Pancreatic Neoplasms.
Connection Strength
0.077
-
Phase 1 clinical trial of the novel proteasome inhibitor marizomib with the histone deacetylase inhibitor vorinostat in patients with melanoma, pancreatic and lung cancer based on in vitro assessments of the combination. Invest New Drugs. 2012 Dec; 30(6):2303-17.
Score: 0.077